MedTrace Logo

Multicenter ACL Revision Study (MARS)

NCT00625885 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1234

Last updated 2025-06-17

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of modifiable risk factors on patient-reported quality of life, physical activity levels, and risk of early osteoarthritis following revision anterior cruciate ligament (ACL) reconstruction.

The investigators hypothesize that modifiable variables exist at the time of revision ACL reconstruction (e.g., cause of failure, current graft source and type, surgical exposure, and femoral and tibial tunnel position) which will be predictors of patient-reported outcomes.

Conditions

  • Rupture of Anterior Cruciate Ligament

Sponsors & Collaborators

  • Vanderbilt University Medical Center

    collaborator OTHER

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Rick W. Wright, M.D. · Vanderbilt University Medical Center

  • Kurt P. Spindler, M.D. · Vanderbilt University Medical Center

Eligibility

Min Age
12 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-26
Primary Completion
2029-06-01
Completion
2029-08-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00625885 on ClinicalTrials.gov